MDT-637

DRUG3 trials

Sponsors

MicroDose Therapeutx, Inc

Conditions

Drug SafetyRespiratory Syncytial Virus Infections

Phase 1

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers

CompletedNCT01355016

MicroDose Therapeutx, IncDrug Safety, Respiratory Syncytial Virus Infections

Start: 2011-09-30End: 2011-11-30Target: 48Updated: 2012-04-12

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers

CompletedNCT01489306

MicroDose Therapeutx, IncDrug Safety

Start: 2011-12-31End: 2012-02-29Target: 36Updated: 2012-04-12

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma

CompletedNCT01556607

MicroDose Therapeutx, IncDrug Safety

Start: 2012-03-31End: 2012-05-31Target: 10Updated: 2012-05-22